{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:14:57Z","timestamp":1780614897503,"version":"3.54.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T00:00:00Z","timestamp":1680393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.phrs.2023.106757","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T17:38:14Z","timestamp":1680716294000},"page":"106757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["LKB1 signaling and patient survival outcomes in hepatocellular carcinoma"],"prefix":"10.1016","volume":"192","author":[{"given":"Khoa","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Awoyode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh K.","family":"Alahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Izadpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgette M.","family":"Collins-Burow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Drewry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Burow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2023.106757_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tcb.2008.01.008","article-title":"LKB1 and AMPK in cell polarity and division","volume":"18","author":"Williams","year":"2008","journal-title":"Trends Cell Biol."},{"issue":"9","key":"10.1016\/j.phrs.2023.106757_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2443.2012.01629.x","article-title":"LKB1 and AMP-activated protein kinase: regulators of cell polarity","volume":"17","author":"Nakano","year":"2012","journal-title":"Genes Cells"},{"issue":"10","key":"10.1016\/j.phrs.2023.106757_bib3","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/jcp.25786","article-title":"Lkb1 regulation of skeletal muscle development, metabolism and muscle progenitor cell homeostasis","volume":"232","author":"Shan","year":"2017","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.phrs.2023.106757_bib4","article-title":"Critical role of Lkb1 in the maintenance of alveolar macrophage self-renewal and immune homeostasis","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2023.106757_bib5","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/stem.1788","article-title":"Lkb1 is indispensable for skeletal muscle development, regeneration, and satellite cell homeostasis","volume":"32","author":"Shan","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2023.106757_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-94-007-4584-1_11","article-title":"Ion channel regulation by the LKB1-AMPK signalling pathway: the key to carotid body activation by hypoxia and metabolic homeostasis at the whole body level","volume":"758","author":"Evans","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"issue":"7324","key":"10.1016\/j.phrs.2023.106757_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nature09595","article-title":"Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells","volume":"468","author":"Gan","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2023.106757_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ceb.2018.05.004","article-title":"Mechanisms linking mechanotransduction and cell metabolism","volume":"54","author":"Salvi","year":"2018","journal-title":"Curr. Opin. Cell Biol."},{"issue":"6663","key":"10.1016\/j.phrs.2023.106757_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/34432","article-title":"A serine\/threonine kinase gene defective in Peutz-Jeghers syndrome","volume":"391","author":"Hemminki","year":"1998","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.phrs.2023.106757_bib11","first-page":"4549","article-title":"Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice","volume":"62","author":"Nakau","year":"2002","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.phrs.2023.106757_bib12","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.181006","article-title":"Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma","volume":"5","author":"Menyhart","year":"2018","journal-title":"R. Soc. Open Sci."},{"issue":"4","key":"10.1016\/j.phrs.2023.106757_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1475-4924-2-28","article-title":"Complexes between the LKB1 tumor suppressor, STRAD alpha\/beta and MO25 alpha\/beta are upstream kinases in the AMP-activated protein kinase cascade","volume":"2","author":"Hawley","year":"2003","journal-title":"J. Biol."},{"issue":"8","key":"10.1016\/j.phrs.2023.106757_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1-AMPK pathway: metabolism and growth control in tumour suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.phrs.2023.106757_bib15","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/emboj\/cdg292","article-title":"Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD","volume":"22","author":"Baas","year":"2003","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.phrs.2023.106757_bib16","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s13577-022-00782-6","article-title":"RNF126 contributes to stem cell-like properties and metastasis in hepatocellular carcinoma through ubiquitination and degradation of LKB1","volume":"35","author":"Huang","year":"2022","journal-title":"Hum. Cell"},{"issue":"9","key":"10.1016\/j.phrs.2023.106757_bib17","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.7150\/jca.72021","article-title":"LKB1 inhibits proliferation, metastasis and angiogenesis of thyroid cancer by upregulating SIK1","volume":"13","author":"Kou","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.phrs.2023.106757_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.847505","article-title":"Liver kinase B1 regulates remodeling of the tumor microenvironment in triple-negative breast cancer","volume":"9","author":"King","year":"2022","journal-title":"Front Mol. Biosci."},{"issue":"1","key":"10.1016\/j.phrs.2023.106757_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s42003-022-03103-7","article-title":"TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS\/LKB1 mutant NSCLC in humanized mouse model","volume":"5","author":"Meraz","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.phrs.2023.106757_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1749-8104-9-5","article-title":"STRAD pseudokinases regulate axogenesis and LKB1 stability","volume":"9","author":"Veleva-Rotse","year":"2014","journal-title":"Neural Dev."},{"issue":"22","key":"10.1016\/j.phrs.2023.106757_bib21","doi-asserted-by":"crossref","first-page":"18758","DOI":"10.1074\/jbc.M111.316422","article-title":"STE20-related kinase adaptor protein alpha (STRADalpha) regulates cell polarity and invasion through PAK1 signaling in LKB1-null cells","volume":"287","author":"Eggers","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.phrs.2023.106757_bib22","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1093\/emboj\/cdg490","article-title":"MO25alpha\/beta interact with STRADalpha\/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm","volume":"22","author":"Boudeau","year":"2003","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.phrs.2023.106757_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078334","article-title":"Cell cycle regulated interaction of a yeast Hippo kinase and its activator MO25\/Hym1","volume":"8","author":"Hsu","year":"2013","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.phrs.2023.106757_bib24","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1080\/15384101.2021.1933303","article-title":"miR-451 suppresses EMT and metastasis in glioma cells","volume":"20","author":"Nan","year":"2021","journal-title":"Cell Cycle"},{"key":"10.1016\/j.phrs.2023.106757_bib25","doi-asserted-by":"crossref","first-page":"3702061","DOI":"10.1155\/2021\/3702061","article-title":"Retracted: MiR-451 promotes cell proliferation and metastasis in pancreatic cancer through targeting CAB39","volume":"2021","author":"International","year":"2021","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.phrs.2023.106757_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320957143","article-title":"HPV16 E6\/E7 promote the translocation and glucose uptake of GLUT1 by PI3K\/AKT pathway via relieving miR-451 inhibitory effect on CAB39 in lung cancer cells","volume":"11","author":"Wang","year":"2020","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"5","key":"10.1016\/j.phrs.2023.106757_bib27","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41416-019-0703-3","article-title":"MiR-107 confers chemoresistance to colorectal cancer by targeting calcium-binding protein 39","volume":"122","author":"Liang","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2023.106757_bib28","article-title":"Circular RNA circGSK3B promotes cell proliferation, migration, and invasion by sponging miR-1265 and regulating CAB39 expression in hepatocellular carcinoma","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106757_bib29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1074\/jbc.271.2.611","article-title":"Mammalian AMP-activated protein kinase subfamily","volume":"271","author":"Stapleton","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106757_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1242\/jcs.259609","article-title":"AMPK promotes Arf6 activation in a kinase-independent manner upon glucose starvation","volume":"135","author":"Chen","year":"2022","journal-title":"J. Cell Sci."},{"issue":"5","key":"10.1016\/j.phrs.2023.106757_bib31","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s10571-020-01025-8","article-title":"Concurrent Akt, ERK1\/2 and AMPK activation by obestatin inhibits apoptotic signaling cascades on nutrient-deprived PC12 cells","volume":"42","author":"Sanchez-Temprano","year":"2022","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2023.106757_bib32","doi-asserted-by":"crossref","first-page":"8730816","DOI":"10.1155\/2019\/8730816","article-title":"LKB1\/AMPK pathway and drug response in cancer: a therapeutic perspective","volume":"2019","author":"Ciccarese","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"issue":"5","key":"10.1016\/j.phrs.2023.106757_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188785","article-title":"AMPK: an odyssey of a metabolic regulator, a tumor suppressor, and now a contextual oncogene","volume":"1877","author":"Penugurti","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2023.106757_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2004.06.007","article-title":"The LKB1 tumor suppressor negatively regulates mTOR signaling","volume":"6","author":"Shaw","year":"2004","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.phrs.2023.106757_bib35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"issue":"24","key":"10.1016\/j.phrs.2023.106757_bib36","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-18-0585","article-title":"CAMKK2 promotes prostate cancer independently of AMPK via increased lipogenesis","volume":"78","author":"Penfold","year":"2018","journal-title":"Cancer Res."},{"issue":"25","key":"10.1016\/j.phrs.2023.106757_bib37","doi-asserted-by":"crossref","first-page":"38822","DOI":"10.18632\/oncotarget.9615","article-title":"Downregulation of HSP60 disrupts mitochondrial proteostasis to promote tumorigenesis and progression in clear cell renal cell carcinoma","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.phrs.2023.106757_bib38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41388-019-1004-2","article-title":"AMPKalpha1 confers survival advantage of colorectal cancer cells under metabolic stress by promoting redox balance through the regulation of glutathione reductase phosphorylation","volume":"39","author":"Wang","year":"2020","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.phrs.2023.106757_bib39","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1093\/emboj\/cdg447","article-title":"MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK\/PAR-1","volume":"22","author":"Timm","year":"2003","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.phrs.2023.106757_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005917","article-title":"Stabilization of microtubule-unbound tau via tau phosphorylation at Ser262\/356 by Par-1\/MARK contributes to augmentation of AD-related phosphorylation and abeta42-induced tau toxicity","volume":"12","author":"Ando","year":"2016","journal-title":"PLoS Genet."},{"issue":"11","key":"10.1016\/j.phrs.2023.106757_bib41","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnen\/59.11.966","article-title":"Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study","volume":"59","author":"Chin","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106757_bib42","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1523\/JNEUROSCI.2824-07.2008","article-title":"The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy","volume":"28","author":"Mocanu","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2023.106757_bib43","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bcp.2010.03.029","article-title":"Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells","volume":"80","author":"Wu","year":"2010","journal-title":"Biochem Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2023.106757_bib44","doi-asserted-by":"crossref","first-page":"570","DOI":"10.15252\/embr.201540970","article-title":"miR-515-5p controls cancer cell migration through MARK4 regulation","volume":"17","author":"Pardo","year":"2016","journal-title":"EMBO Rep."},{"issue":"11","key":"10.1016\/j.phrs.2023.106757_bib45","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1074\/jbc.RA118.004984","article-title":"Transforming growth factor beta (TGFbeta) induces NUAK kinase expression to fine-tune its signaling output","volume":"294","author":"Kolliopoulos","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.phrs.2023.106757_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133377","article-title":"NUAK1 and NUAK2 Fine-Tune TGF-beta signaling","volume":"13","author":"van de Vis","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.phrs.2023.106757_bib47","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.emboj.7600110","article-title":"LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK\/PAR-1","volume":"23","author":"Lizcano","year":"2004","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.phrs.2023.106757_bib48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2007.12.033","article-title":"Visualizing spatiotemporal dynamics of multicellular cell-cycle progression","volume":"132","author":"Sakaue-Sawano","year":"2008","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2023.106757_bib49","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41392-020-00265-w","article-title":"The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis","volume":"5","author":"Sun","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"3","key":"10.1016\/j.phrs.2023.106757_bib50","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbrc.2010.02.037","article-title":"Targeting of renal proximal tubule Na,K-ATPase by salt-inducible kinase","volume":"393","author":"Taub","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2023.106757_bib51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fonc.2019.00018","article-title":"Salt-inducible kinase 2: an oncogenic signal transmitter and potential target for cancer therapy","volume":"9","author":"Chen","year":"2019","journal-title":"Front Oncol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106757_bib52","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1158\/1541-7786.MCR-13-0182-T","article-title":"Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer","volume":"13","author":"Bon","year":"2015","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.phrs.2023.106757_bib53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ccell.2016.06.020","article-title":"Salt-inducible kinase 2 couples ovarian cancer cell metabolism with survival at the adipocyte-rich metastatic niche","volume":"30","author":"Miranda","year":"2016","journal-title":"Cancer Cell"},{"issue":"42","key":"10.1016\/j.phrs.2023.106757_bib54","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1215450109","article-title":"Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages","volume":"109","author":"Clark","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.phrs.2023.106757_bib55","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1074\/jbc.M112.431239","article-title":"Reversible acetylation regulates salt-inducible kinase (SIK2) and its function in autophagy","volume":"288","author":"Yang","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.phrs.2023.106757_bib56","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1158\/1078-0432.CCR-16-1562","article-title":"A novel compound ARN-3236 inhibits salt-inducible kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel","volume":"23","author":"Zhou","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2023.106757_bib57","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2019.10.029","article-title":"SIK2 promotes reprogramming of glucose metabolism through PI3K\/AKT\/HIF-1alpha pathway and Drp1-mediated mitochondrial fission in ovarian cancer","volume":"469","author":"Gao","year":"2020","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.phrs.2023.106757_bib58","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3109\/10428191003699878","article-title":"Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphoma","volume":"51","author":"Nagel","year":"2010","journal-title":"Leuk. Lymphoma"},{"issue":"8","key":"10.1016\/j.phrs.2023.106757_bib59","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1096\/fj.12-205609","article-title":"Salt-inducible kinase 1 regulates E-cadherin expression and intercellular junction stability","volume":"26","author":"Eneling","year":"2012","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.phrs.2023.106757_bib60","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jhep.2016.01.005","article-title":"Salt-inducible Kinase (SIK1) regulates HCC progression and WNT\/beta-catenin activation","volume":"64","author":"Qu","year":"2016","journal-title":"J. Hepatol."},{"issue":"80","key":"10.1016\/j.phrs.2023.106757_bib61","doi-asserted-by":"crossref","first-page":"ra35","DOI":"10.1126\/scisignal.2000369","article-title":"SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis","volume":"2","author":"Cheng","year":"2009","journal-title":"Sci. Signal"},{"issue":"86","key":"10.1016\/j.phrs.2023.106757_bib62","doi-asserted-by":"crossref","first-page":"pe55","DOI":"10.1126\/scisignal.286pe55","article-title":"Tumor suppression by LKB1: SIK-ness prevents metastasis","volume":"2","author":"Shaw","year":"2009","journal-title":"Sci. Signal"},{"issue":"4","key":"10.1016\/j.phrs.2023.106757_bib63","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1517\/14728222.2016.1101452","article-title":"The diverse oncogenic and tumor suppressor roles of salt-inducible kinase (SIK) in cancer","volume":"20","author":"Du","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"issue":"6","key":"10.1016\/j.phrs.2023.106757_bib64","doi-asserted-by":"crossref","DOI":"10.1046\/j.1471-4159.2000.0742227.x","article-title":"The salt-inducible kinase, SIK, is induced by depolarization in brain","volume":"74","author":"Feldman","year":"2000","journal-title":"J. Neurochem"},{"issue":"20","key":"10.1016\/j.phrs.2023.106757_bib65","doi-asserted-by":"crossref","first-page":"18440","DOI":"10.1074\/jbc.M211770200","article-title":"Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2","volume":"278","author":"Horike","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2023.106757_bib66","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41389-022-00395-6","article-title":"Salt-Inducible Kinase 1 is a potential therapeutic target in desmoplastic small round cell tumor","volume":"11","author":"Hartono","year":"2022","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.phrs.2023.106757_bib67","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.2042-3306.1991.tb02717.x","article-title":"Osteochondral fracture of the proximal palmar middle phalanx in a Thoroughbred","volume":"23","author":"Welch","year":"1991","journal-title":"Equine Vet. J."},{"issue":"31","key":"10.1016\/j.phrs.2023.106757_bib68","doi-asserted-by":"crossref","first-page":"21876","DOI":"10.18632\/oncotarget.25082","article-title":"SIK2 attenuates proliferation and survival of breast cancer cells with simultaneous perturbation of MAPK and PI3K\/Akt pathways","volume":"9","author":"Zohrap","year":"2018","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.phrs.2023.106757_bib69","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/tox.23366","article-title":"Salt-inducible kinase 2 functions as a tumor suppressor in hepatocellular carcinoma","volume":"36","author":"Li","year":"2021","journal-title":"Environ. Toxicol."},{"issue":"33","key":"10.1016\/j.phrs.2023.106757_bib70","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1038\/onc.2011.77","article-title":"Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer","volume":"30","author":"Charoenfuprasert","year":"2011","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.phrs.2023.106757_bib71","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1158\/2159-8290.CD-18-1261","article-title":"The AMPK-related kinases SIK1 and SIK3 mediate key tumor-suppressive effects of LKB1 in NSCLC","volume":"9","author":"Hollstein","year":"2019","journal-title":"Cancer Disco"},{"issue":"22","key":"10.1016\/j.phrs.2023.106757_bib72","doi-asserted-by":"crossref","first-page":"14946","DOI":"10.1074\/jbc.M710381200","article-title":"Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation","volume":"283","author":"Bright","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2023.106757_bib73","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000450616","article-title":"Putative tumor suppressor genes EGR1 and BRSK1 are mutated in gastric and colorectal cancers","volume":"91","author":"Choi","year":"2016","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.phrs.2023.106757_bib74","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.yexmp.2014.07.012","article-title":"Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K\/Akt pathway","volume":"97","author":"Wang","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"27","key":"10.1016\/j.phrs.2023.106757_bib75","doi-asserted-by":"crossref","first-page":"44669","DOI":"10.18632\/oncotarget.17965","article-title":"BRSK2 induced by nutrient deprivation promotes Akt activity in pancreatic cancer via downregulation of mTOR activity","volume":"8","author":"Saiyin","year":"2017","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.phrs.2023.106757_bib76","first-page":"1084","article-title":"Clinical implication of BRSK2 expression in pancreatic ductal adenocarcinoma","volume":"90","author":"Niu","year":"2010","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.phrs.2023.106757_bib77","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1432-1033.1996.00736.x","article-title":"Molecular cloning and characterization of a novel mammalian protein kinase harboring a homology domain that defines a subfamily of serine\/threonine kinases","volume":"235","author":"Becker","year":"1996","journal-title":"Eur. J. Biochem."},{"issue":"6","key":"10.1016\/j.phrs.2023.106757_bib78","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.febslet.2005.01.042","article-title":"Identification of the sucrose non-fermenting related kinase SNRK, as a novel LKB1 substrate","volume":"579","author":"Jaleel","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2023.106757_bib79","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.molmet.2019.07.009","article-title":"Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue","volume":"28","author":"Li","year":"2019","journal-title":"Mol. Metab."},{"issue":"50","key":"10.1016\/j.phrs.2023.106757_bib80","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1038\/s41388-018-0402-1","article-title":"CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1alpha axis to inhibit gastric tumorigenesis","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.phrs.2023.106757_bib81","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/ATVBAHA.117.309834","article-title":"SNRK (sucrose nonfermenting 1-related kinase) promotes angiogenesis in vivo","volume":"38","author":"Lu","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2023.106757_bib82","article-title":"SNRK: a metabolic regulator with multifaceted role in development and disease","volume":"4","author":"Thirugnanam","year":"2020","journal-title":"Vessel"},{"issue":"7","key":"10.1016\/j.phrs.2023.106757_bib83","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/07357907.2017.1337781","article-title":"Sucrose non-fermenting related kinase expression in ovarian cancer and correlation with clinical features","volume":"35","author":"Hopp","year":"2017","journal-title":"Cancer Invest"},{"issue":"11","key":"10.1016\/j.phrs.2023.106757_bib84","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1096\/fj.12-212282","article-title":"Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of beta-catenin","volume":"26","author":"Rines","year":"2012","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.phrs.2023.106757_bib85","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.18632\/oncotarget.27929","article-title":"Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment","volume":"12","author":"Nguyen","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2023.106757_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115198","article-title":"AMPKalpha2\/HNF4A\/BORIS\/GLUT4 pathway promotes hepatocellular carcinoma cell invasion and metastasis in low glucose microenviroment","volume":"203","author":"Huang","year":"2022","journal-title":"Biochem Pharm."},{"issue":"7","key":"10.1016\/j.phrs.2023.106757_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119242","article-title":"MARK2\/4 promotes Warburg effect and cell growth in non-small cell lung carcinoma through the AMPKalpha1\/mTOR\/HIF-1alpha signaling pathway","volume":"1869","author":"Natarajan","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:43:13Z","timestamp":1760913793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823001135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":86,"alternative-id":["S1043661823001135"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106757","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LKB1 signaling and patient survival outcomes in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106757"}}